ONO Golden Ticket 2025 Winner

ONO and MBC BioLabs are delighted to announce ResNovas Therapeutics as the winner of the 2025 Golden Ticket Competition. Congratulations to the ResNovas Therapeutics team! 

ResNovas is a preclinical-stage biotech developing novel therapeutic approaches for highly validated but historically undruggable targets in oncology and beyond.

Ono Pharmaceutical Co., Ltd. delivers innovative therapies for patients worldwide. Upholding its philosophy of “Dedicated to the Fight against Disease and Pain,” ONO targets areas with unmet medical needs including oncology, immunology and neurology, and fosters partnerships with academic and biotech organizations to accelerate drug discovery. Through its affiliate, Deciphera Pharmaceuticals, ONO is accelerating clinical development and commercial operations in the US and Europe to drive global business expansion and further its commitment to patient care. For more information, please visit the company’s website at https://www.ono-pharma.com/en.